173 related articles for article (PubMed ID: 34793446)
1. Osteoblast-specific inactivation of p53 results in locally increased bone formation.
Liao N; Koehne T; Tuckermann J; Triviai I; Amling M; David JP; Schinke T; Luther J
PLoS One; 2021; 16(11):e0249894. PubMed ID: 34793446
[TBL] [Abstract][Full Text] [Related]
2. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.
Ng AJ; Walia MK; Smeets MF; Mutsaers AJ; Sims NA; Purton LE; Walsh NC; Martin TJ; Walkley CR
PLoS Genet; 2015 Apr; 11(4):e1005160. PubMed ID: 25859855
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
[TBL] [Abstract][Full Text] [Related]
4. The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.
Baldauf C; Jeschke A; Kanbach V; Catala-Lehnen P; Baumhoer D; Gerull H; Buhs S; Amling M; Nollau P; Harroch S; Schinke T
PLoS One; 2015; 10(9):e0137745. PubMed ID: 26360410
[TBL] [Abstract][Full Text] [Related]
5. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
Elife; 2016 Apr; 5():. PubMed ID: 27070462
[TBL] [Abstract][Full Text] [Related]
6. Essential role of RSK2 in c-Fos-dependent osteosarcoma development.
David JP; Mehic D; Bakiri L; Schilling AF; Mandic V; Priemel M; Idarraga MH; Reschke MO; Hoffmann O; Amling M; Wagner EF
J Clin Invest; 2005 Mar; 115(3):664-72. PubMed ID: 15719069
[TBL] [Abstract][Full Text] [Related]
7. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton.
Yorgan T; Vollersen N; Riedel C; Jeschke A; Peters S; Busse B; Amling M; Schinke T
Bone; 2016 Jun; 87():136-46. PubMed ID: 27102824
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
10. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.
Berman SD; Calo E; Landman AS; Danielian PS; Miller ES; West JC; Fonhoue BD; Caron A; Bronson R; Bouxsein ML; Mukherjee S; Lees JA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11851-6. PubMed ID: 18697945
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
[TBL] [Abstract][Full Text] [Related]
13. Loss of p53 compensates osteopenia in murine Mysm1 deficiency.
Haffner-Luntzer M; Kovtun A; Fischer V; Prystaz K; Hainzl A; Kroeger CM; Krikki I; Brinker TJ; Ignatius A; Gatzka M
FASEB J; 2018 Apr; 32(4):1957-1968. PubMed ID: 29203593
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
[TBL] [Abstract][Full Text] [Related]
15. WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma.
Del Mare S; Husanie H; Iancu O; Abu-Odeh M; Evangelou K; Lovat F; Volinia S; Gordon J; Amir G; Stein J; Stein GS; Croce CM; Gorgoulis V; Lian JB; Aqeilan RI
Cancer Res; 2016 Oct; 76(20):6107-6117. PubMed ID: 27550453
[TBL] [Abstract][Full Text] [Related]
16. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
[TBL] [Abstract][Full Text] [Related]
17. cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma.
He Y; Zhu W; Shin MH; Gary J; Liu C; Dubois W; Hoover SB; Jiang S; Marrogi E; Mock B; Simpson RM; Huang J
Stem Cell Reports; 2017 Jun; 8(6):1630-1644. PubMed ID: 28552607
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell.
Wang JY; Chen CM; Chen CF; Wu PK; Chen WM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681897
[TBL] [Abstract][Full Text] [Related]
19. EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling.
Linder M; Glitzner E; Srivatsa S; Bakiri L; Matsuoka K; Shahrouzi P; Dumanic M; Novoszel P; Mohr T; Langer O; Wanek T; Mitterhauser M; Wagner EF; Sibilia M
EMBO Mol Med; 2018 Nov; 10(11):. PubMed ID: 30361264
[TBL] [Abstract][Full Text] [Related]
20. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.
Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3310-5. PubMed ID: 16492765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]